Participants in a study by the company Noble show that the vast majority of patients—92%—would prefer to bring home a training device to practice with prior to starting self-injection. Noble creates… Read More »
Joe Reynolds leverages the knowledge of the pharmaceutical and medical device industries to derive insights and maximize value for all members of the Noble healthcare team. His experience includes work… Read More »
Desperate for relief, many people living with inflammatory bowel disease (IBD)—either Crohn’s disease or ulcerative colitis—rely on biologic therapies that require users to self-inject. Because self-injecting can be a daunting… Read More »
Innovation is vital for survival in the pharma industry. Although huge amounts of time, money and creativity are conventionally spent on the clinical development and commercialization of new drugs, success… Read More »
Although there are many positive changes impacting self-injecting patients, there are also some challenges patients and other stakeholders face, including training decay from lengthy gaps between self-administration, forgetfulness… Read More »